Alzheimer sufferers now have access to new drugs

The video discusses the availability of new drugs for treating early-stage Alzheimer's on the NHS, following a reversal by NICE. Initially, NICE had restricted these drugs, requiring patients to wait until symptoms worsened. New evidence led to a change, allowing wider access. The drugs, including Rennell, can stabilize symptoms for six months, improving patients' quality of life. NICE also approved Obexer for severe symptoms, offering an alternative to sedation.

What new insight or understanding did you gain from this video?